[HTML][HTML] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

R Gilson, D Nugent, K Bennett, CJ Doré… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

[PDF][PDF] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

R Gilson, D Nugent, K Bennett, CJ Doré… - Health Technology …, 2020 - researchgate.net
Richard Gilson o, 1, 2* Diarmuid Nugent o, 1, 2 Kate Bennett o, 3 Caroline J Doré o, 3
Macey L Murray o, 3 Jade Meadows o, 3 Lewis J Haddow o, 1, 2 Charles Lacey o, 4 Frank …

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

R Gilson, D Nugent, K Bennett… - HEALTH …, 2020 - researchonline.lshtm.ac.uk
BACKGROUND: The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

R Gilson, D Nugent, K Bennett, C Dore… - Health Technology …, 2020 - discovery.ucl.ac.uk
BACKGROUND: The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

R Gilson, D Nugent, K Bennett… - Health Technology …, 2020 - journalslibrary.nihr.ac.uk
Background The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

[HTML][HTML] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

R Gilson, D Nugent, K Bennett, CJ Doré… - Health Technology …, 2020 - europepmc.org
Background The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

[HTML][HTML] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

R Gilson, D Nugent, K Bennett, CJ Doré, ML Murray… - 2020 - ncbi.nlm.nih.gov
Background: The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

[PDF][PDF] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

R Gilson, D Nugent, K Bennett, CJ Doré… - Health Technology …, 2020 - scholar.archive.org
Richard Gilson o, 1, 2* Diarmuid Nugent o, 1, 2 Kate Bennett o, 3 Caroline J Doré o, 3
Macey L Murray o, 3 Jade Meadows o, 3 Lewis J Haddow o, 1, 2 Charles Lacey o, 4 Frank …

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

R Gilson, D Nugent, K Bennett, CJ Doré, ML Murray… - 2020 - pubmed.ncbi.nlm.nih.gov
Background The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

[HTML][HTML] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

R Gilson, D Nugent, K Bennett, CJ Doré… - Health Technology …, 2020 - europepmc.org
Background The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …